Millennium Management’s Organogenesis Holdings ORGO Stock Holding History

Millennium Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-483,742	Closed	-$2.51M	–	6190
2025 Q4	$2.51M	Buy	483,742 +400,514	+481%	+$1.94M	﹤0.01%	3741
2025 Q3	$351K	Sell	83,228 -55,752	-40%	-$259K	﹤0.01%	5271
2025 Q2	$509K	Sell	138,980 -22,071	-14%	-$82.3K	﹤0.01%	4900
2025 Q1	$696K	Sell	161,051 -47,369	-23%	-$191K	﹤0.01%	4615
2024 Q4	$667K	Buy	208,420 +5,765	+3%	+$19.3K	﹤0.01%	4524
2024 Q3	$580K	Buy	202,655 +68,812	+51%	+$193K	﹤0.01%	4712
2024 Q2	$375K	Sell	133,843 -76,913	-36%	-$206K	﹤0.01%	4780
2024 Q1	$599K	Sell	210,756 -735,458	-78%	-$2.5M	﹤0.01%	4698
2023 Q4	$3.87M	Sell	946,214 -373,714	-28%	-$1.05M	﹤0.01%	3011
2023 Q3	$4.2M	Sell	1,319,928 -859,158	-39%	-$2.73M	﹤0.01%	2855
2023 Q2	$7.23M	Buy	2,179,086 +594,812	+38%	+$1.76M	﹤0.01%	2328
2023 Q1	$3.38M	Sell	1,584,274 -142,988	-8%	-$353K	﹤0.01%	2955
2022 Q4	$4.65M	Buy	1,727,262 +231,733	+15%	+$676K	﹤0.01%	2876
2022 Q3	$4.85M	Buy	1,495,529 +929,727	+164%	+$4.2M	﹤0.01%	2915
2022 Q2	$2.76M	Sell	565,802 -856,176	-60%	-$5.27M	﹤0.01%	3382
2022 Q1	$10.8M	Buy	1,421,978 +227,852	+19%	+$1.76M	0.01%	2073
2021 Q4	$11M	Buy	1,194,126 +698,263	+141%	+$7.42M	0.01%	2043
2021 Q3	$7.06M	Sell	495,863 -494,584	-50%	-$7.68M	﹤0.01%	2479
2021 Q2	$16.5M	Buy	990,447 +758,062	+326%	+$14.1M	0.01%	1385
2021 Q1	$4.23M	Buy	232,385 +135,384	+140%	+$1.83M	﹤0.01%	2764
2020 Q4	$730K	Buy	+97,001	New	+$461K	﹤0.01%	3938
2020 Q2	–	Sell	-78,956	Closed	-$255K	–	4482
2020 Q1	$255K	Sell	78,956 -82,830	-51%	-$355K	﹤0.01%	3265
2019 Q4	$778K	Buy	+161,786	New	+$1.03M	﹤0.01%	3118
2019 Q3	–	Sell	-16,878	Closed	-$128K	–	4454
2019 Q2	$128K	Sell	16,878 -42,337	-71%	-$311K	﹤0.01%	3854
2019 Q1	$444K	Buy	+59,215	New	+$1.18M	﹤0.01%	3342
2018 Q3	–	Sell	-500,000	Closed	-$5.01M	–	4176
2018 Q2	$5.01M	Buy	+500,000	New	+$5.01M	0.01%	1818

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management's ORGO Position: Q1 2026 in Review

Millennium Management sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 483,742 shares — an estimated $2.51M sold.

Millennium Management first reported a position in ORGO in Q2 2018 and held it in 26 quarters. The position peaked at $16.5M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Millennium Management reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
Millennium Management sold 483,742 Organogenesis Holdings shares in Q1 2026, an estimated $2.51M.
Millennium Management first reported a position in Organogenesis Holdings in Q2 2018 and held it in 26 quarters.
Millennium Management's Organogenesis Holdings position peaked at $16.5M in Q2 2021.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.